Incretins, pregnancy, and gestational diabetes

Dragana Nikolic, Khalid Al-Rasadi, Noor Al Busaidi, Khalid Al-Waili, Yajnavalka Banerjee, Khamis Al-Hashmi, Giuseppe Montalto, Ali A. Rizvi, Manfredi Rizzo, Tamima Al-Dughaishi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The number of pregnant women affected by gestational diabetes mellitus (GDM) is increasing among Caucasians, and East Asians. GDM also increases the risk for later advent of type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease in both women and their offspring. The underlying mechanism of GDM is not fully elucidated. Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), have been suggested to have a role in maternal metabolism and weight as well as fetal growth. These hormones might be implicated in mechanisms that compensate for the increment in glycemia and insulin resistance seen during pregnancy, while other factors, such as heredity, environment and lifestyle, but also different race/ethnic background might also lead to the comorbid health problems. Some studies indicate that pregnancy is associated with a diminished GLP-1 response which is more prominently evident in women with GDM and normalizes after delivery. Postprandial GIP level seems to be unaffected by pregnancy, despite its increased level in GDM. On the other hand, the reduced incretin effect observed in GDM may represent a risk factor for obesity, T2DM and metabolic disorders even in the offspring of these women. Further investigations are needed to establish the exact role of incretins in pregnancy and gestational glucose intolerance.

Original languageEnglish
Pages (from-to)597-602
Number of pages6
JournalCurrent Pharmaceutical Biotechnology
Volume17
Issue number7
Publication statusPublished - Jun 1 2016

Keywords

  • Gestational diabetes
  • Incretins
  • Obesity
  • Pregnancy
  • Type 2 diabetes

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Biotechnology

Fingerprint Dive into the research topics of 'Incretins, pregnancy, and gestational diabetes'. Together they form a unique fingerprint.

  • Cite this

    Nikolic, D., Al-Rasadi, K., Busaidi, N. A., Al-Waili, K., Banerjee, Y., Al-Hashmi, K., Montalto, G., Rizvi, A. A., Rizzo, M., & Al-Dughaishi, T. (2016). Incretins, pregnancy, and gestational diabetes. Current Pharmaceutical Biotechnology, 17(7), 597-602.